1. Reciprocal Regulation of ERα and ERβ Stability and Activity by Diptoindonesin G.
- Author
-
Zhao Z, Wang L, James T, Jung Y, Kim I, Tan R, Hoffmann FM, and Xu W
- Subjects
- Benzofurans chemistry, Blotting, Western, Breast Neoplasms therapy, Cell Line, Tumor, Cell Proliferation drug effects, Estrogen Receptor alpha genetics, Estrogen Receptor alpha metabolism, Estrogen Receptor beta genetics, Estrogen Receptor beta metabolism, Female, Gene Expression Regulation, Neoplastic drug effects, Humans, Molecular Docking Simulation, Protein Stability drug effects, Small Molecule Libraries chemistry, Small Molecule Libraries pharmacology, Structure-Activity Relationship, Benzofurans pharmacology, Estrogen Receptor alpha drug effects, Estrogen Receptor beta drug effects
- Abstract
ERβ is regarded as a "tumor suppressor" in breast cancer due to its anti-proliferative effects. However, unlike ERα, ERβ has not been developed as a therapeutic target in breast cancer due to loss of ERβ in aggressive cancers. In a small-molecule library screen for ERβ stabilizers, we identified Diptoindonesin G (Dip G), which significantly increases ERβ protein stability while decreasing ERα protein levels. Dip G enhances the transcription and anti-proliferative activities of ERβ, while attenuating the transcription and proliferative effects of ERα. Further investigation revealed that instead of targeting ER, Dip G targets the CHIP E3 ubiquitin ligase shared by ERα and ERβ. Thus, Dip G is a dual-functional moiety that reciprocally controls ERα and ERβ protein stability and activities via an indirect mechanism. The ERβ stabilization effects of Dip G may enable the development of ERβ-targeted therapies for human breast cancers., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF